Michael A. Archer

Michael A. Archer

Auto-generated profile, based on publicly available information

Michael A. Archer

Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
JLJessica G.Y. Luc
Jessica G.Y. Luc
MAMichael A. Archer
Michael A. Archer
RARakesh C. Arora
Rakesh C. Arora
EBEdward M. Bender
Edward M. Bender
ABArie Blitz
Arie Blitz
MAMara Antonoff
Mara Antonoff

14 January 2016 in Cancer Research
Verified
Journal Article
Closed access
PDF file
ARAssunta De Rienzo
Assunta De Rienzo
MAMichael A. Archer
Michael A. Archer
BYBeow Y. Yeap
Beow Y. Yeap
NDNhien Dao
Nhien Dao
DSDaniele Sciaranghella
Daniele Sciaranghella
RBRaphael Bueno
Raphael Bueno
Malignant pleural mesothelioma (MPM) is an aggressive cancer that occurs more frequently in men, but is associated with longer survival in women. Insight into the survival advantage of female patients may advance the molecular understanding of MPM and identify therapeutic interventions that will improve the prognosis for all MPM patients. In this study, we performed whole-genome sequencing of tumor specimens from 10 MPM patients and matched control samples to identify potential driver mutations underlying MPM. We identified molecular differences associated with gender and histology. Specifically, single-nucleotide variants of BAP1 were observed in 21% of cases, with lower mutation rates observed in sarcomatoid MPM (P < 0.001). Chromosome 22q loss was more frequently associated with the epithelioid than that nonepitheliod histology (P = 0.037), whereas CDKN2A deletions occurred more frequently in nonepithelioid subtypes among men (P = 0.021) and were correlated with shorter overall survival for the entire cohort (P = 0.002) and for men (P = 0.012). Furthermore, women were more likely to harbor TP53 mutations (P = 0.004). Novel mutations were found in genes associated with the integrin-linked kinase pathway, including MYH9 and RHOA. Moreover, expression levels of BAP1, MYH9, and RHOA were significantly higher in nonepithelioid tumors, and were associated with significant reduction in survival of the entire cohort and across gender subgroups. Collectively, our findings indicate that diverse mechanisms highly related to gender and histology appear to drive MPM. Cancer Res; 76(2); 319–28. ©2015 AACR.

1 January 2015 in Journal of Thoracic Oncology
Verified
Journal Article
Open access
PDF file
RBRaphael Bueno
Raphael Bueno
EHElisha Hughes
Elisha Hughes
SWSusanne Wagner
Susanne Wagner
AGAlexander S. Gutin
Alexander S. Gutin
JLJerry S. Lanchbury
Jerry S. Lanchbury
DHDavid Harrison
David Harrison
Lung cancer is one of the most common cancers in the United States and Europe and the leading cause of cancer death for both men and women in the United States, with approximately 160,000 patient deaths per year. Nonsmall cell lung cancer (NSCLC) comprises 85% of lung cancer cases of which up to 40% have adenocarcinoma histology. Patients diagnosed with stage I and II adenocarcinoma (localized disease) have 5-year overall mortality rates ranging from 30% in stage IA, 50% in stage IB disease, and up to 66% in stage II.1 x 1 Tsuboi, M, Ohira, T, Saji, H et al. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2007; 13: 73–77 PubMed | Google Scholar See all References ,2 x 2 Chansky, K, Sculier, JP, Crowley, JJ, Giroux, D, Van Meerbeeck, J, and Goldstraw, P. International Staging Committee and Participating Institutions. . The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009; 4: 792–801 Abstract | Full Text | Full Text PDF | PubMed | Scopus (267) | Google Scholar See all References

1 January 2020 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
THTamara Ni Hici
Tamara Ni Hici
MAMichael Archer
Michael Archer
CHCaitlin Harrington
Caitlin Harrington
JLJessica G.Y. Luc
Jessica G.Y. Luc
MAMara B. Antonoff
Mara B. Antonoff

1 November 2017 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
NMNitin Mehdiratta
Nitin Mehdiratta
MAMichael Archer
Michael Archer
MSMelissa Stewart
Melissa Stewart
BDBradley Dennis
Bradley Dennis
EGEric Grogan
Eric Grogan